ABEONA THERAPEUTICS INC. Increase (Decrease) in Restricted Investments for Operating Activities
ABEONA THERAPEUTICS INC. (ABEO) reported Increase (Decrease) in Restricted Investments for Operating Activities of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities · last filed 2014-03-26
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for the quarter ending 2013-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for the quarter ending 2011-12-31 was $330.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for fiscal 2013 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for fiscal 2012 was -$330.00K, a 200.00% decline from fiscal 2011.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for fiscal 2011 was $330.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in restricted investments for operating activities for fiscal 2010 was -$17.00K.
| Period end | Increase (Decrease) in Restricted Investments for Operating Activities 3 month | Increase (Decrease) in Restricted Investments for Operating Activities 9 month | Increase (Decrease) in Restricted Investments for Operating Activities 9 month as first filed | Increase (Decrease) in Restricted Investments for Operating Activities 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 10-K · filed 2014-03-26 | ||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$330.00K 10-K · filed 2014-03-26 | ||
| 2012-09-30 | -$330.00K 10-Q · filed 2013-11-14 | $330.00K 10-Q · filed 2012-11-14 | ||
| 2011-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $330.00K 10-K · filed 2013-03-20 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | |||
| 2010-12-31 | -$17.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |